MSP Recovery (NASDAQ: LIFW) has been on quite the rollercoaster ride, defying gravity with over 400% gain since September 14th, 2023 with over 240% of that gain happening this week alone. However, the exact reasons behind this meteoric rise remain elusive. Typically, when a company drops major news, you’d expect an instant stock reaction. But in this case, the last significant update from the company was about a week ago, and it’s questionable whether that news was much on the positive side, yet the stock is still zooming upwards.

Background:
Let’s delve into the nitty-gritty of what MSP Recovery, more prominently known as LifeWallet, is all about. Imagine them as the healthcare financial detectives, diligently sifting through the complexities of medical billing and reimbursements. They specialize in recovering money owed to healthcare providers. If an insurance company owes a hospital for a patient’s treatment, these folks ensure that the hospital gets the rightful compensation. But their innovation doesn’t stop there.
Enter “LifeWallet,” their brainchild—a powerful tool designed to revolutionize healthcare transactions. Picture it as a savvy assistant for healthcare professionals, standing by their side in the hustle and bustle of medical care. LifeWallet’s magic lies in its ability to decipher the complexities of healthcare billing and insurance. It guides doctors and hospitals, helping them navigate the tangled web of who should foot the bill, especially in post-accident treatments. It’s a digital ally ensuring fair compensation and smooth financial transactions in the intricate healthcare landscape.
Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
MSP is making waves in the healthcare domain with this innovative approach, leveraging data analytics to streamline processes and champion fair compensation for healthcare providers. Much like a rollercoaster ride, their journey promises excitement, surprises, and an undeniable thrill in the world of healthcare finances.
Legal Battles and CEO Extravagnce:
Step back and look at their stock chart—MSP has taken a major hit in value this year, and it’s not without reason. Surprisingly, digging into the company’s operations revealed some unpleasant surprises we hadn’t anticipated. It’s been a rough ride for them.
The company was just recently involved in a class action law suit led by recognized leader in shareholder rights litigation, Robbins LLP. The case revolved around MSP not providing essential information to investors transparently.
There were a number of claims mentioned, here’s a quick list.
- MSP didn’t reveal there was an ongoing investigation by the SEC and federal prosecutors.
- They gave out financial information to investors that was significantly wrong and deceptive.
- When admitting they needed to fix their financial results, they didn’t reveal the full extent of the issues.
- MSP couldn’t financially handle the claims they were assigned to manage by a major health and engaged in deceitful actions with said provider
- The Registration Statement had lots of wrong or misleading statements and was poorly prepared.
- Their Proxy also had false or misleading statements.
It all started on July 31, 2023, where The Miami Herald unveiled significant revelations. Stating the CEO John H. Ruiz has been living quite the lifestyle buying several waterfront mansions in Miami, even an entire Boeing passenger jet.
It’s not surprising the Ruiz’s lifestyle was so extravagant considering LifeWallet was once valued at more than $32 billion, but as you can see the company is now worth a small fraction of that. That said, Ruiz’s expensive lifestyle would be tough to continue.
Then again, on August 1, 2023, the Company made disclosures to the SEC (Form 8-K), confirming The Miami Herald’s findings. The stock took another substantial hit, dropping over 12%. Adding to the unfolding drama. After that, a substantial $67 million lawsuit was filed against the Company on the same day, resulting in an 18% plummet in the stock price.
The narrative continues on! On August 17, 2023, MSP acknowledged a notification letter from Nasdaq’s Listing Qualifications Department. They confirmed the Company’s non-compliance with Nasdaq’s Rule 5250(c)(1) due to a delayed Form 10-Q filing for the period ending June 30, 2023. This revelation caused a 19% stock price drop over two days.
With that said, we’ll bet you’re seriously wondering how could this company could possibly see recovery (pun intended) after all these allegations were laid out.
What happened:
Surprisingly enough, it seems Robbins LLP just recently lost the case against MSP and there was an announcement made on September 13th, 2023 about it. All those allegations have vanished into thin air. It’s baffling how a company with so many strikes against it can seemingly wrap things up so quickly. The whole situation leaves us questioning what’s really going on.
Since the announcement the other week, the company’s valuation has skyrocketed, at some points even peaking at an increase of over 400%. Naturally with that kind of trading action, it’s no surprise day traders are getting in on the action. MSP is trending all over Twitter amongst notable users like @timothysykes, @stockplaymaker1, and @AngryRed316 talking about it.
At this point, it looks like investors are basing their trades more on chart patterns and less on the company’s solid financial footing. MSP didn’t deliver great news in its latest earnings report, showing quite a large net loss of over $400 million. It’s quite likely the allegations had a role to play in this financial blow. The real question is if MSP can get its act together, start making real profits, and avoid a chapter 11. Either way, we’ll continue to follow along to see how things pan out!
We will update you on LIFW when more details emerge, subscribe to Microcapdaily to follow along!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Picture geralt by from Pixabay.com
Chris Lonsford
November 15, 2020 at 7:35 pm
Recent high was 2.51 not 0.51
Justin Kinney
November 15, 2020 at 7:40 pm
Thanks Longsford. Anyone else have anything to add?
joe pratt
November 15, 2020 at 10:24 pm
https://www.dropbox.com/sh/tlagm94xvkr4eah/AADYWl2TLEu9wzG5P1-nPp9ja?dl=0&preview=Cognate+PILOT+Application.pdf
By Greg Akers – Editor-in-Chief, Memphis Business Journal
Nov 13, 2020, 3:04pm CST Updated Nov 13, 2020, 3:29pm CST
A bioscience company with a large local presence is planning a new investment that would create hundreds of jobs and see three industrial sites receive major renovations and new construction.
Cognate BioServices Inc. plans to renovate three properties for “cell-therapy operations, contract development, and manufacturing for drug sponsors, and related logistics.”
The company is seeking a 15-year Jobs PILOT (payment-in-lieu-of-taxes) from the Economic Development Growth Engine (EDGE) for Memphis and Shelby County. The incentive would be worth $52 million, and be based on a $212 million project investment.
The investment would include $126 million in construction costs and $71 million in personal property. It covers sites at 4600 E. Shelby Drive, 5780 E. Shelby Drive, and 6100 Global Drive.
See ihub 330449
https://microcapdaily.wpengine.com/the-powerful-run-on-northwest-biotherapeutics-inc-otcmkts-nwbo/128611/
joseph H pratt
November 15, 2020 at 10:26 pm
ae kusterer Sunday, 11/15/20 09:24:24 PM
Re: None 0
Post #
330550
of 330554
COULD IT BE THAT NWBO WILL LICENSE THE FLASKWORKS TECHNOLOGY TO COGNATE?
https://nwbio.com/northwest-biotherapeutics-acquires-flaskworks-breakthrough-automation-technology-for-cell-therapy-products-to-enable-scale-up-of-production-volumes-and-reduction-of-production-costs/
“The Flaskworks system will follow the same batch-manufacturing process – doing so in a “closed” and automated manner.
Certain optimization work will be required so that the Flaskworks system will produce DCVax-L products with characteristics equivalent to the products made by the current DCVax-L manufacturing processes. This will then need to be confirmed by comparability studies. The Flaskworks technical team will work with NW Bio’s contract manufacturers to accomplish this. In the meantime, the Company’s DCVax products will continue to be made through the existing processes.”
https://www.dropbox.com/sh/tlagm94xvkr4eah/AADYWl2TLEu9wzG5P1-nPp9ja?dl=0&preview=Cognate+PILOT+Application.pdf
http://www.growth-engine.org/news/events/wednesday-november-18-2020-edge-board-meetings/
https://www.bizjournals.com/memphis/
KaOsiris Friday, 11/13/20 04:57:54 PM
Re: None 0
Post #
330131
of 330199
Cognate BioServices plans $212M investment in Memphis ops
Memphis Business Journal
By Greg Akers
Editor-in-Chief, Memphis Business Journal
Nov 13, 2020, 3:04pm CST
Updated 26 minutes ago